Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
- DOI
- 10.1182/bloodadvances.2025016141
- Published
- 2025-10-30
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025016141,
title = {Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR},
author = {Kitsada Wudhikarn and Megan M. Herr and Min Chen and Michael J. Martens and John H. Baird and Lohith Gowda and Hemalatha G. Rangarajan and Muhammad Bilal Abid and Mohamed A. Kharfan-Dabaja and Kirsten M. Williams and Siddhartha Ganguly and Jo-Anne H. Young and Akshay Sharma and Giancarlo Fatobene and Tania Jain and Christopher G. Kanakry and Dipenkumar Modi and Natalie S. Grover and Baheyeldin Salem and Marjorie Vieira Batista and Paschalis Vergidis and Dwight E. Yin and Amer M. Beitinjaneh and Amar H. Kelkar and Taiga Nishihori and Jennifer Holter Chakrabarty and Usama Gergis and Melody Smith and Zeinab El Boghdadly and Christopher E. Dandoy and Hemant S. Murthy and Anna R. Huppler and Miguel-Angel Perales and Roy F. Chemaly and Joshua A. Hill and Marcie Riches and Jeffery J. Auletta},
year = {2025},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2025016141},
url = {https://doi.org/10.1182/bloodadvances.2025016141}
}RIS
TY - JOUR TI - Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR AU - Kitsada Wudhikarn AU - Megan M. Herr AU - Min Chen AU - Michael J. Martens AU - John H. Baird AU - Lohith Gowda AU - Hemalatha G. Rangarajan AU - Muhammad Bilal Abid AU - Mohamed A. Kharfan-Dabaja AU - Kirsten M. Williams AU - Siddhartha Ganguly AU - Jo-Anne H. Young AU - Akshay Sharma AU - Giancarlo Fatobene AU - Tania Jain AU - Christopher G. Kanakry AU - Dipenkumar Modi AU - Natalie S. Grover AU - Baheyeldin Salem AU - Marjorie Vieira Batista AU - Paschalis Vergidis AU - Dwight E. Yin AU - Amer M. Beitinjaneh AU - Amar H. Kelkar AU - Taiga Nishihori AU - Jennifer Holter Chakrabarty AU - Usama Gergis AU - Melody Smith AU - Zeinab El Boghdadly AU - Christopher E. Dandoy AU - Hemant S. Murthy AU - Anna R. Huppler AU - Miguel-Angel Perales AU - Roy F. Chemaly AU - Joshua A. Hill AU - Marcie Riches AU - Jeffery J. Auletta PY - 2025 JO - Blood Advances DO - 10.1182/bloodadvances.2025016141 UR - https://doi.org/10.1182/bloodadvances.2025016141 ER -
APA
Wudhikarn, K., Herr, M. M., Chen, M., Martens, M. J., Baird, J. H., Gowda, L., Rangarajan, H. G., Abid, M. B., Kharfan-Dabaja, M. A., Williams, K. M., Ganguly, S., Young, J. H., Sharma, A., Fatobene, G., Jain, T., Kanakry, C. G., Modi, D., Grover, N. S., Salem, B., Batista, M. V., Vergidis, P., Yin, D. E., Beitinjaneh, A. M., Kelkar, A. H., Nishihori, T., Chakrabarty, J. H., Gergis, U., Smith, M., Boghdadly, Z. E., Dandoy, C. E., Murthy, H. S., Huppler, A. R., Perales, M., Chemaly, R. F., Hill, J. A., Riches, M., & Auletta, J. J. (2025). Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Advances. https://doi.org/10.1182/bloodadvances.2025016141
Source records
- crossref · retrieved 2026-09-26T17:16:42.146Z